Variant report
Variant | nsv526661 |
---|---|
Chromosome Location | chr2:34519194-34532515 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RASGRP3-1 | chr2:34522535-34522820 | ENSG00000203386 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76977084 | chr2:34519201-34519202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556151622 | chr2:34519206-34519207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189661018 | chr2:34519214-34519215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113193521 | chr2:34519273-34519274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560799833 | chr2:34519274-34519275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558662816 | chr2:34519277-34519278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572139412 | chr2:34519282-34519283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149916366 | chr2:34519327-34519328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12465251 | chr2:34519344-34519345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574211082 | chr2:34519401-34519402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144947475 | chr2:34519408-34519409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181028080 | chr2:34519422-34519423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531577900 | chr2:34519435-34519436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73928247 | chr2:34519436-34519437 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs6728480 | chr2:34519448-34519449 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs527829462 | chr2:34519522-34519523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547225805 | chr2:34519536-34519537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs114433713 | chr2:34519566-34519567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529980059 | chr2:34519613-34519614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149048451 | chr2:34519622-34519623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73928248 | chr2:34519625-34519626 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs185893088 | chr2:34519645-34519646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376106727 | chr2:34519720-34519721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12613086 | chr2:34519779-34519780 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs565593065 | chr2:34519796-34519797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76376945 | chr2:34519801-34519802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534724818 | chr2:34519803-34519804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6743914 | chr2:34519806-34519807 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs144425630 | chr2:34519894-34519895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9308949 | chr2:34519922-34519923 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs556427170 | chr2:34519927-34519928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375554294 | chr2:34519929-34519930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377589915 | chr2:34519931-34519932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375394654 | chr2:34519932-34519933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs70940243 | chr2:34519933-34519934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575112008 | chr2:34519941-34519942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs386389901 | chr2:34519943-34519944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs397984277 | chr2:34519947-34519948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576372150 | chr2:34519958-34519959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11897172 | chr2:34519983-34519984 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs548694317 | chr2:34519992-34519993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565282724 | chr2:34520010-34520011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527740466 | chr2:34520014-34520015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541529415 | chr2:34520047-34520048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570042423 | chr2:34520057-34520058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147816506 | chr2:34520076-34520077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112595039 | chr2:34520084-34520085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550034785 | chr2:34520115-34520116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190461540 | chr2:34520123-34520124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs114463679 | chr2:34520152-34520153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34519200-34520400 | Enhancers | Fetal Lung | lung |
2 | chr2:34528200-34528600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |